Search

Author/Creator Lyon, Rebecca

1. An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2. Issue 3 (13th November 2021)

Authors:
Walker, Lauren E.; FitzGerald, Richard; Saunders, Geoffrey; Lyon, Rebecca; Fisher, Michael; Martin, Karen; Eberhart, Izabela; Woods, Christie; Ewings, Sean; Hale, Colin; Rajoli, Rajith K. R.; Else, Laura; Dilly‐Penchala, Sujan; Amara, Alieu; Lalloo, David G.; Jacobs, Michael; Pertinez, Henry; Hat...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 111:Issue 3(2022)
Page Start:
585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Issue 2 (February 2023)

Authors:
Khoo, Saye H; FitzGerald, Richard; Saunders, Geoffrey; Middleton, Calley; Ahmad, Shazaad; Edwards, Christopher J; Hadjiyiannakis, Dennis; Walker, Lauren; Lyon, Rebecca; Shaw, Victoria; Mozgunov, Pavel; Periselneris, Jimstan; Woods, Christie; Bullock, Katie; Hale, Colin; Reynolds, Helen; Downs, Ni...
Journal:
Lancet infectious diseases
Issue:
Volume 23:Issue 2(2023)
Page Start:
183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. (27th August 2021)

Authors:
Khoo, Saye H; Fitzgerald, Richard; Fletcher, Thomas; Ewings, Sean; Jaki, Thomas; Lyon, Rebecca; Downs, Nichola; Walker, Lauren; Tansley-Hancock, Olana; Greenhalf, William; Woods, Christie; Reynolds, Helen; Marwood, Ellice; Mozgunov, Pavel; Adams, Emily; Bullock, Katie; Holman, Wayne; Bula, Marcin...
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 76:Number 12(2021)
Page Start:
3286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. (10th March 2022)

Authors:
FitzGerald, Richard; Dickinson, Laura; Else, Laura; Fletcher, Thomas; Hale, Colin; Amara, Alieu; Walker, Lauren; Penchala, Sujan Dilly; Lyon, Rebecca; Shaw, Victoria; Greenhalf, William; Bullock, Katie; Lavelle-Langham, Lara; Reynolds, Helen; Painter, Wendy; Holman, Wayne; Ewings, Sean; Griffiths...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 1(2022)
Page Start:
e525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Issue 10318 (18th December 2021)

Authors:
Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; va...
Journal:
Lancet
Issue:
Volume 398:Issue 10318(2021)
Page Start:
2258
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Issue 8 (August 2022)

Authors:
Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Al...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 8(2022)
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗